Total Funding
18
28
Total FundingPost-IPO Equity raised
Growth Score
-1 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
175413
Alimera Sciences is a biopharmaceutical company that focuses on retinal health.
Acquired by 
ANI Pharmaceuticals
- Rick Eiswirth: CEO, President & Director
- Ken Greene: Chief Scientific Officer
About the Company
Alimera Sciences is a pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. The company is passionate about protecting the retina and developing innovative treatments to preserve vision.
